1 week Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here’s What You Should KnowZacks
The consensus price target hints at a 31.4% upside potential for Adaptive Biotechnologies (ADPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
X